Improving participation and diversity in gynecologic cancer trials
Enhancing accrual and diversity across gynecologic and solid tumor trials
['FUNDING_OTHER'] · UNIVERSITY OF VIRGINIA · NIH-10777158
This study is working to make it easier for women with gynecologic cancers to join clinical trials, so they can access new and better treatments by finding and fixing the obstacles that keep patients and doctors from participating.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF VIRGINIA (nih funded) |
| Locations | 1 site (CHARLOTTESVILLE, UNITED STATES) |
| Trial ID | NIH-10777158 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the recruitment and diversity of participants in clinical trials focused on gynecologic cancers. The approach involves identifying and addressing barriers that prevent patients and providers from participating in these trials. The Principal Investigator, who is both a practicing Gynecologic Oncologist and a clinical researcher, will leverage their unique position to foster collaborations and mentorships that promote new clinical trial initiatives. By building a robust clinical research infrastructure, the project seeks to improve access to innovative treatments for women with gynecologic malignancies.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with gynecologic malignancies who are seeking treatment options through clinical trials.
Not a fit: Patients with non-gynecologic cancers or those not interested in participating in clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more inclusive and effective clinical trials, ultimately improving treatment options for women with gynecologic cancers.
How similar studies have performed: Previous research has shown that targeted efforts to enhance diversity and participation in clinical trials can lead to improved patient outcomes and more representative data.
Where this research is happening
CHARLOTTESVILLE, UNITED STATES
- UNIVERSITY OF VIRGINIA — CHARLOTTESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DUSKA, LINDA — UNIVERSITY OF VIRGINIA
- Study coordinator: DUSKA, LINDA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Comprehensive Cancer Center, Female Reproductive Cancer, Gynecologic Cancer